Lakewood-Amedex Biotherapeutics Inc. - (LABT) share price
Lakewood-Amedex Biotherapeutics Inc. - (NASDAQ:LABT) last traded at $0.39, down 28.54% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.00B and a 52-week range of $0.17 to $98.2.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $0.39 |
| 1-day move | -28.54% |
| 52-week range | $0.17 - $98.2 |
| Market cap | $0.00B |
| From 52-week high | -99.60% |
| Volume vs average | 2.5x |
| Falling Shares risk score | 72/100 (CRITICAL) |
| Country | United States |
Frequently asked questions
Why is Lakewood-Amedex Biotherapeutics Inc. - falling today?
Lakewood-Amedex Biotherapeutics Inc. - (NASDAQ:LABT) is down 28.54% at its latest quote and trades 99.6% below its 52-week high, on volume 2.5x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Lakewood-Amedex Biotherapeutics Inc. - share price today?
Lakewood-Amedex Biotherapeutics Inc. - (NASDAQ:LABT) last traded at $0.39, a -28.54% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Lakewood-Amedex Biotherapeutics Inc. -?
Lakewood-Amedex Biotherapeutics Inc. -'s 52-week low is $0.17 and its 52-week high is $98.2; the shares trade 99.6% below the high.
What is the market cap of Lakewood-Amedex Biotherapeutics Inc. -?
Lakewood-Amedex Biotherapeutics Inc. - has a market capitalisation of about $0.00B at the latest price.
What are the risks of investing in Lakewood-Amedex Biotherapeutics Inc. -?
Falling Shares Intelligence rates Lakewood-Amedex Biotherapeutics Inc. - 72/100 (CRITICAL) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com